This guideline covers safe and effective use of medicines in health and social care for people taking 1 or more medicines. It aims to ensure that medicines provide the greatest possible benefit to people by encouraging medicines reconciliation, medication review, and the use of patient decision aids.
NICE has also produced a guideline on medicines adherence.
This guideline includes recommendations on:
- systems for identifying, reporting and learning from medicines-related patient safety incidents
- medicines-related communication systems for when patients move from one care setting to another
- medicines reconciliation and medication review
- self-management plans
- patient decision aids
Who is it for?
- Healthcare professionals
- Social care practitioners
- Commissioners and providers
- People taking 1 or more medicines and their families and carers
Guideline development process
This guideline updates and replaces recommendation 1.4.2 in the NICE guideline on medicines adherence. It also updates and replaces NICE guideline PSG001 (December 2007).
Next review: March 2019
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.